Description
Epirubicin is classified as an anthracycline antibiotic and is preferred for its significantly lower cardiotoxicity which makes it safer for elderly patients with breast cancer.
Indication:
As a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer
|
Generic Name |
Strength |
Standard |
Type |
Packing |
Pack Size |
|
Epirubicin |
10 mg |
BP |
INJ |
Vial |
Vial |
|
Epirubicin |
50 mg |
BP |
INJ |
Vial |
Vial |

0
Reviews
There are no reviews yet.